Overview

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.
Phase:
Phase 3
Details
Lead Sponsor:
Toronto Rehabilitation Institute
Collaborators:
Ontario Neurotrauma Foundation
Queen Elizabeth Hospital NHS Foundation Trust
St. Joseph's Healthcare Foundation
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid